May 2014 early tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2013/14 Invitation to Tender, dated 07 November 2013.
Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and notification of product change (NOPC) forms can be found on our website.
Where a product does not have a current pharmacode, suppliers are required to ensure a pharmacode has been obtained from the Pharmacy Guild of New Zealand before the 12th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct pharmacode.
IMPORTANT NOTICE: MID MONTH NOTIFICATION
PHARMAC is notifying the tender award of the following products earlier than the usual end of month notification to make sure all interested parties are aware as soon as possible.
PHARMAC also wishes to make it known that the incoming brand will not be available on the 12th of the month prior to listing but by the second week of July.
2013/14 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2017
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type |
Current subsidy and (price) | New subsidy and price | Sole supply brand (Supplier) |
Date of listing/subsidy change for tender winning brand | Date of reference pricing of other listed brands | Sole Subsidised Supply date (and delisting of other listed brands) | Brand (Supplier) affected by reference pricing and delisting |
|---|---|---|---|---|---|---|---|---|
| Amoxicillin | Grans for oral liq 125 mg per 5 ml; 100 ml bottle |
$1.55 | $0.88 | Arrow-Amoxicillin (Actavis) |
1 July 2014* | 1 October 2014 | 1 January 2015 | Ospamox (Sandoz) |
| Amoxicillin | Grans for oral liq 250 mg per 5 ml; 100 ml bottle |
$1.10 | $0.97 | Arrow-Amoxicillin (Actavis) |
1 July 2014* | 1 October 2014 | 1 January 2015 | Ospamox (Sandoz) |
| *Please note that the product will not be available from the 12th of the month prior to listing but by the 2nd week of July. | ||||||||
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
| Chemical Name | Presentation; Pack size and type |
Current pack price | New pack price |
Hospital Supply Brand (Supplier) | DV Limit | Date of listing/price change for tender winning brand | Hospital Supply Status date (and delisting of other listed brands) | Brand (Supplier) to be delisted |
|---|---|---|---|---|---|---|---|---|
| Amoxicillin | Grans for oral liq 125 mg per 5 ml; 100 ml bottle |
$1.55 | $0.88 | Arrow-Amoxicillin (Actavis) |
1% | 1 July 2014* | 1 October 2014 | Ospamox (Sandoz) |
| Amoxicillin | Grans for oral liq 250 mg per 5 ml; 100 ml bottle |
$1.10 | $0.97 | Arrow-Amoxicillin (Actavis) |
1% | 1 July 2014* | 1 October 2014 | Ospamox (Sandoz) |
|
*Please note that the product will not be available from the 12th of the month prior to listing but by the 2nd week of July |
||||||||
For products included in the 2011/12 Invitation to Tender, 2012/13 or the 2013/14 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate’s) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.